Viewing Study NCT00776802


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2025-12-26 @ 2:32 AM
Study NCT ID: NCT00776802
Status: WITHDRAWN
Last Update Posted: 2013-06-25
First Post: 2008-10-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor: La Jolla Pharmaceutical Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module